HUMANIGEN, INC Uncategorized Contracts & Agreements
11 Contracts & Agreements
- Description of Securities (Filed With SEC on March 10, 2021)
- INDEMNITY AGREEMENT (Filed With SEC on March 10, 2021)
- Clinical Trial Agreement, dated as of July 24, 2020, by and between Humanigen, Inc. and The National Institute of Allergy and Infectious Diseases (NIAID), part of the National... (Filed With SEC on July 30, 2020)
- DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 (Filed With SEC on March 16, 2020)
- Offer Letter, dated August 16, 2017, by and between the Registrant and Greg Jester (Filed With SEC on March 27, 2018)
- KaloBios Pharmaceuticals, Inc. 1000 Marina Blvd., Suite 250 Brisbane, CA 94005 (Filed With SEC on July 12, 2017)
- KaloBios Pharmaceuticals, Inc. 1000 Marina Blvd., Suite 250 Brisbane, CA 94005 (Filed With SEC on March 23, 2017)
- [Signature Page to Follow] (Filed With SEC on September 23, 2016)
- CorporateGovernance agreement (Filed With SEC on July 6, 2016)
- IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE (Filed With SEC on June 22, 2016)
- [KALOBIOS LETTERHEAD] (Filed With SEC on August 10, 2015)
